glp-1 news today october 2025 Pipeline Update: November - Prime Therapeutics What's next for GLP-1 weight-loss

Research indicates that NNMT expression correlates positively with insulin resistance, with plasma levels of the NNMT product 1-methylnicotinamide associated with increased body mass index and metabolic dysfunction

Injectable B12 bypasses absorption issues and is first-line treatment for malabsorption conditions, whilst oral doses of 1,0002,000 g daily may suit dietary deficiency without malabsorption

Proudfoot AT, Wright N

However, compared with other lipid mediators, there has been relatively limited research on the role of lipid rafts in immune cell-based disease therapies

Membranes were blocked with 5% milk in TBS-T solution, then incubated with primary antibody (phospho-STAT5 alpha (TYR694), Invitrogen, 716,900